Skip to main content
Livermore
Livermore
ZHEN

First Trust Advisors LP

SEC CIK
0001125816
Latest filing
Aug 11, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
289,179
Value
$143.6M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by First Trust Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026289,179$143.6M0.1%−17,282−5.6%ReducedHolders
Q1 2026306,461$136.8M0.1%+105,171+52.2%AddedHolders
Q4 2025201,290$91.3M0.1%+13,129+7.0%AddedHolders
Q3 2025188,161$73.7M0.1%−99,731−34.6%ReducedHolders
Q2 2025287,892$128.2M0.1%+143,084+98.8%AddedHolders
Q1 2025144,808$70.2M0.1%−47,978−24.9%ReducedHolders
Q4 2024192,786$77.6M0.1%−382,246−66.5%ReducedHolders
Q3 2024575,032$267.4M0.3%+371,691+182.8%AddedHolders
Q2 2024203,341$95.3M0.1%−27,856−12.0%ReducedHolders
Q1 2024231,197$96.6M0.1%−503,638−68.5%ReducedHolders
Q4 2023734,835$299.0M0.3%−63,531−8.0%ReducedHolders
Q3 2023798,366$277.6M0.3%+508,389+175.3%AddedHolders
Q2 2023289,977$102.0M0.1%−42,809−12.9%ReducedHolders
Q1 2023332,786$104.9M0.1%−17,185−4.9%ReducedHolders
Q4 2022349,971$101.1M0.1%−10,921−3.0%ReducedHolders
Q3 2022360,892$104.5M0.1%−668,540−64.9%ReducedHolders
Q2 20221,029,432$290.1M0.4%+588,620+133.5%AddedHolders
Q1 2022440,812$115.0M0.1%−80,615−15.5%ReducedHolders
Q4 2021521,427$114.5M0.1%+30,756+6.3%AddedHolders
Q3 2021490,671$89.0M0.1%+91,357+22.9%AddedHolders
Q2 2021399,314$80.5M0.1%+11,734+3.0%AddedHolders
Q1 2021387,580$83.3M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.